T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Schlumberger
SLB
|
$2.5B |
| 2 |
Kenvue
KVUE
|
$1.3B |
| 3 |
Halliburton
HAL
|
$1.16B |
| 4 |
Charles Schwab
SCHW
|
$836M |
| 5 |
Boeing
BA
|
$832M |
Top Sells
| 1 |
Microsoft
MSFT
|
$2.52B |
| 2 |
Apple
AAPL
|
$1.77B |
| 3 |
Advanced Micro Devices
AMD
|
$1.57B |
| 4 |
Johnson & Johnson
JNJ
|
$1.47B |
| 5 |
Intuit
INTU
|
$1.14B |
Sector Composition
| 1 | Technology | 29.85% |
| 2 | Healthcare | 16.84% |
| 3 | Financials | 10.89% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Esperion Therapeutics
ESPR
$512M
| $35K | ﹤0.01% |
35,400
+19,800
| +127% | +$19.6K |
|
2802
SelectQuote
SLQT
$353M
| $35K | ﹤0.01% |
29,488
+3,088
| +12% | +$3.67K |
|
|
EMKR
2803
DELISTED
Emcore Corp
EMKR
| $35K | ﹤0.01% |
7,160
| – | – |
|
|
SRTA
2804
Strata Critical Medical, Inc. Class A Common Stock
SRTA
$330M
| $34K | ﹤0.01% |
12,847
+1,280
| +11% | +$3.39K |
|
2805
Bionano Genomics
BNGO
$19.8M
| $34K | ﹤0.01% |
183
+88
| +93% | +$16.4K |
|
2806
Bit Digital
BTBT
$829M
| $34K | ﹤0.01% |
15,469
+791
| +5% | +$1.74K |
|
2807
CEL-SCI Corp
CVM
$70.7M
| $34K | ﹤0.01% |
893
| – | – |
|
2808
Nautilus Biotechnolgy
NAUT
$84.3M
| $34K | ﹤0.01% |
10,450
+438
| +4% | +$1.43K |
|
|
PHLT
2809
Performant Healthcare, Inc. Common Stock
PHLT
$604M
| $34K | ﹤0.01% |
14,681
+1,012
| +7% | +$2.34K |
|
2810
AEye
LIDR
$119M
| $33K | ﹤0.01% |
5,097
+2,664
| +109% | +$17.2K |
|
|
PSTX
2811
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $33K | ﹤0.01% |
13,831
| – | – |
|
2812
Dakota Gold
DC
$520M
| $32K | ﹤0.01% |
+12,125
| New | +$32K |
|
2813
KULR Technology Group
KULR
$171M
| $32K | ﹤0.01% |
10,975
| – | – |
|
2814
Westwater Resources
WWR
$61.3M
| $31K | ﹤0.01% |
45,000
| – | – |
|
2815
Kaltura
KLTR
$236M
| $30K | ﹤0.01% |
16,888
| – | – |
|
2816
Shattuck Labs
STTK
$91M
| $30K | ﹤0.01% |
19,300
| – | – |
|
2817
X4 Pharmaceuticals
XFOR
$74.5M
| $30K | ﹤0.01% |
893
+59
| +7% | +$1.98K |
|
|
VLD
2818
DELISTED
Velo3D, Inc.
VLD
| $30K | ﹤0.01% |
534
| – | – |
|
2819
BlackSky Technology
BKSY
$589M
| $30K | ﹤0.01% |
3,203
+200
| +7% | +$1.87K |
|
2820
FiscalNote
NOTE
$63.9M
| $29K | ﹤0.01% |
1,133
+78
| +7% | +$2K |
|
2821
CareCloud
CCLD
$146M
| $28K | ﹤0.01% |
23,700
-9,500
| -29% | -$11.2K |
|
2822
Phunware
PHUN
$51.5M
| $28K | ﹤0.01% |
3,094
+1,522
| +97% | +$13.8K |
|
2823
Altimmune
ALT
$332M
| $27K | ﹤0.01% |
10,047
-15,600
| -61% | -$41.9K |
|
2824
Protalix BioTherapeutics
PLX
$126M
| $27K | ﹤0.01% |
15,982
+4,535
| +40% | +$7.66K |
|
2825
Cartesian Therapeutics
RNAC
$268M
| $26K | ﹤0.01% |
789
-727
| -48% | -$24K |
|